Search

Author/Creator Connett, Gary

1. Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches. (2nd June 2016)

Authors:
Lund-Palau, Helena; Turnbull, Andrew R.; Bush, Andrew; Bardin, Emmanuelle; Cameron, Loren; Soren, Odel; Wierre-Gore, Natasha; Alton, Eric W. F. W.; Bundy, Jacob G.; Connett, Gary; Faust, Saul N.; Filloux, Alain; Freemont, Paul; Jones, Andy; Khoo, Valerie; Morales, Sandra; Murphy, Ronan; Pabary, R...
Journal:
Expert review of respiratory medicine
Issue:
Volume 10:Number 6(2016)
Page Start:
685
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The impact of plasma 25‐hydroxyvitamin D on pulmonary function and exercise physiology in cystic fibrosis: A multicentre retrospective study. Issue 2 (1st June 2021)

Authors:
Revuelta Iniesta, Raquel; Causer, Adam J.; Arregui‐Fresneda, Irantzu; Connett, Gary; Allenby, Mark I.; Daniels, Thomas; Carroll, Mary P.; Urquhart, Don S.; Saynor, Zoe L.
Journal:
Journal of human nutrition and dietetics
Issue:
Volume 35:Issue 2(2022)
Page Start:
363
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Elexacaftor–Tezacaftor–Ivacaftor improves exercise capacity in adolescents with cystic fibrosis. Issue 11 (22nd July 2022)

Authors:
Causer, Adam J.; Shute, Janis K.; Cummings, Michael H.; Shepherd, Anthony I.; Wallbanks, Samuel R.; Pulsford, Richard M.; Bright, Victoria; Connett, Gary; Saynor, Zoe L.
Journal:
Pediatric pulmonology
Issue:
Volume 57:Issue 11(2022)
Page Start:
2652
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Issue 10212 (23rd November 2019)

Authors:
Heijerman, Harry G M; McKone, Edward F; Downey, Damian G; Van Braeckel, Eva; Rowe, Steven M; Tullis, Elizabeth; Mall, Marcus A; Welter, John J; Ramsey, Bonnie W; McKee, Charlotte M; Marigowda, Gautham; Moskowitz, Samuel M; Waltz, David; Sosnay, Patrick R; Simard, Christopher; Ahluwalia, Neil; Xua...
Journal:
Lancet
Issue:
Volume 394:Issue 10212(2019)
Page Start:
1940
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The ERS approach to e-cigarettes is entirely rational. Issue 5 (7th May 2020)

Authors:
Bush, Andrew; Bhatt, Jayesh Mahendra; Carroll, Will; Child, Frances; Connett, Gary; Doull, Iolo; Gilchrist, Francis; Grigg, Jonathan; Langton-Hewer, Simon; Legg, Julian; Lenney, Warren; Paton, James; Shields, Michael; Sinha, Ian
Journal:
European respiratory journal
Issue:
Volume 55:Issue 5(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial. (10th August 2012)

Authors:
Pike, Katharine; Selby, Anna; Price, Sophie; Warner, John; Connett, Gary; Legg, Julian; Lucas, Jane SA; Peters, Sheila; Buckley, Hannah; Magier, Krzysztof; Foote, Keith; Drew, Kirsty; Morris, Ruth; Lancaster, Nikki; Roberts, Graham
Journal:
Clinical respiratory journal
Issue:
Volume 7:Number 2(2013)
Page Start:
204
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗